The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Webcast
Roy Henry, strategic analyst from University of Miami, explores how clinical integration can evolve your supply chain while discussing the value of
Webcast
In today’s value based health care market, reimbursement is tied to patient outcomes.
Webcast
Dave Reed, vice president, healthcare solutions, Cook Medical, discusses the generational gap in health care supply chain leadership as the field f
Webcast
Colleen Cusick, director of materials management at Johns Hopkins Health System, discusses how she created a basic supply chain education program f
Webcast
AHRMM presents a four-part series on successful collaboration with suppliers.